Tanja B. Jensen

1.6k total citations
18 papers, 1.3k citations indexed

About

Tanja B. Jensen is a scholar working on Hepatology, Epidemiology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Tanja B. Jensen has authored 18 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Hepatology, 17 papers in Epidemiology and 9 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Tanja B. Jensen's work include Hepatitis C virus research (18 papers), Hepatitis B Virus Studies (17 papers) and Monoclonal and Polyclonal Antibodies Research (9 papers). Tanja B. Jensen is often cited by papers focused on Hepatitis C virus research (18 papers), Hepatitis B Virus Studies (17 papers) and Monoclonal and Polyclonal Antibodies Research (9 papers). Tanja B. Jensen collaborates with scholars based in Denmark, United States and Belgium. Tanja B. Jensen's co-authors include Jens Bukh, Judith M. Gottwein, Troels K. H. Scheel, Jannick Prentoe, Anne Mette Hoegh, Yi‐Ping Li, Maria L. Knudsen, Jesper Eugen‐Olsen, Lubna Ghanem and Lotte S. Mikkelsen and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Gastroenterology and PLoS ONE.

In The Last Decade

Tanja B. Jensen

18 papers receiving 1.3k citations

Peers

Countries citing papers authored by Tanja B. Jensen

Since Specialization

Citations

This map shows the geographic impact of Tanja B. Jensen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tanja B. Jensen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tanja B. Jensen more than expected).

Fields of papers citing papers by Tanja B. Jensen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tanja B. Jensen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tanja B. Jensen. The network helps show where Tanja B. Jensen may publish in the future.

Co-authorship network of co-authors of Tanja B. Jensen

This figure shows the co-authorship network connecting the top 25 collaborators of Tanja B. Jensen. A scholar is included among the top collaborators of Tanja B. Jensen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tanja B. Jensen. Tanja B. Jensen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	Inactivated whole hepatitis C virus vaccine employing a licensed adjuvant elicits cross-genotype neutralizing antibodies in mice 2022 ·Journal of Hepatology ·(unknown), Shan Feng, Anna Offersgaard, (unknown), (unknown), (unknown), Tanja B. Jensen, Henrik Krarup, Mansun Law, Jannick Prentoe, Jan Pravsgaard Christensen, Jens Bukh, Judith M. Gottwein	16
2	Development of a downstream process for the production of an inactivated whole hepatitis C virus vaccine 2020 ·Scientific Reports ·(unknown), Anna Offersgaard, (unknown), (unknown), Tanja B. Jensen, (unknown), Ulrik Fahnøe, Jens Bukh, Judith M. Gottwein, Michael W. Wolff	25
3	Recombinant hepatitis C virus genotype 5a infectious cell culture systems expressing minimal JFH1 NS5B sequences permit polymerase inhibitor studies 2018 ·Virology ·Daryl Humes, Santseharay Ramírez, Tanja B. Jensen, Yi‐Ping Li, Judith M. Gottwein, Jens Bukh	3
4	Adaptive Mutations Enhance Assembly and Cell-to-Cell Transmission of a High-Titer Hepatitis C Virus Genotype 5a Core-NS2 JFH1-Based Recombinant 2015 ·Journal of Virology ·(unknown), Jannick Prentoe, Luke W. Meredith, Tanja B. Jensen, Henrik Krarup, Jane A. McKeating, Judith M. Gottwein, Jens Bukh	27
5	Production and characterization of high-titer serum-free cell culture grown hepatitis C virus particles of genotype 1–6 2014 ·Virology ·(unknown), Tanja B. Jensen, Jannick Prentoe, Henrik Krarup, Alfredo Nicosia, Mansun Law, Jens Bukh, Judith M. Gottwein	20
6	Neutralization resistance of hepatitis C virus can be overcome by recombinant human monoclonal antibodies 2013 ·Hepatology ·(unknown), Thomas H. R. Carlsen, Jannick Prentoe, Santseharay Ramírez, Tanja B. Jensen, Xavier Forns, Harvey J. Alter, Steven K. H. Foung, Mansun Law, Judith M. Gottwein, Nina Weis, Jens Bukh	38
7	Neutralizing Antibodies in Patients with Chronic Hepatitis C, Genotype 1, against a Panel of Genotype 1 Culture Viruses: Lack of Correlation to Treatment Outcome 2013 ·PLoS ONE ·(unknown), Tanja B. Jensen, Thomas H. R. Carlsen, Kristian Schønning, Peer Brehm Christensen, Alex Lund Laursen, Henrik Krarup, Jens Bukh, Nina Weis	7
8	Adapted J6/JFH1-Based Hepatitis C Virus Recombinants with Genotype-Specific NS4A Show Similar Efficacies against Lead Protease Inhibitors, Alpha Interferon, and a Putative NS4A Inhibitor 2013 ·Antimicrobial Agents and Chemotherapy ·Judith M. Gottwein, Sanne B. Jensen, Stéphanie B. N. Serre, Lubna Ghanem, Troels K. H. Scheel, Tanja B. Jensen, Henrik Krarup, Nathalie Y. Uzcátegui, Lotte S. Mikkelsen, Jens Bukh	15
9	Differential Efficacy of Protease Inhibitors Against HCV Genotypes 2a, 3a, 5a, and 6a NS3/4A Protease Recombinant Viruses 2011 ·Gastroenterology ·Judith M. Gottwein, Troels K. H. Scheel, Tanja B. Jensen, Lubna Ghanem, Jens Bukh	108
10	MicroRNA-122 antagonism against hepatitis C virus genotypes 1–6 and reduced efficacy by host RNA insertion or mutations in the HCV 5′ UTR 2011 ·Proceedings of the National Academy of Sciences ·Yi‐Ping Li, Judith M. Gottwein, Troels K. H. Scheel, Tanja B. Jensen, Jens Bukh	151
11	Development and Application of Hepatitis C Reporter Viruses with Genotype 1 to 7 Core-Nonstructural Protein 2 (NS2) Expressing Fluorescent Proteins or Luciferase in Modified JFH1 NS5A 2011 ·Journal of Virology ·Judith M. Gottwein, Tanja B. Jensen, (unknown), Philip Meuleman, Stéphanie B. N. Serre, (unknown), Lubna Ghanem, Troels K. H. Scheel, Geert Leroux‐Roels, Jens Bukh	72
12	Recombinant HCV Variants With NS5A From Genotypes 1–7 Have Different Sensitivities to an NS5A Inhibitor but Not Interferon-α 2010 ·Gastroenterology ·Troels K. H. Scheel, Judith M. Gottwein, Lotte S. Mikkelsen, Tanja B. Jensen, Jens Bukh	111
13	Efficient Culture Adaptation of Hepatitis C Virus Recombinants with Genotype-Specific Core-NS2 by Using Previously Identified Mutations 2010 ·Journal of Virology ·Troels K. H. Scheel, Judith M. Gottwein, Thomas H. R. Carlsen, Yi‐Ping Li, Tanja B. Jensen, Ulrich Spengler, Nina Weis, Jens Bukh	72
14	Hypervariable Region 1 Differentially Impacts Viability of Hepatitis C Virus Strains of Genotypes 1 to 6 and Impairs Virus Neutralization 2010 ·Journal of Virology ·Jannick Prentoe, Tanja B. Jensen, Philip Meuleman, Stéphanie B. N. Serre, Troels K. H. Scheel, Geert Leroux‐Roels, Judith M. Gottwein, Jens Bukh	122
15	82 DELETION OF HYPERVARIABLE REGION 1 (HVR1) OF E2 FROM HCV GENOTYPES 1–6 HAS DIFFERENTIAL EFFECT ON INFECTIVITY IN VITRO AND CAUSES INCREASED SUSCEPTIBILITY TO NEUTRALIZATION 2009 ·Journal of Hepatology ·Jannick Prentoe, Judith M. Gottwein, Troels K. H. Scheel, Tanja B. Jensen, Stéphanie B. N. Serre, Jens Bukh	1
16	Development and characterization of hepatitis C virus genotype 1-7 cell culture systems: Role of CD81 and scavenger receptor class B type I and effect of antiviral drugs # † 2008 ·Hepatology ·Judith M. Gottwein, Troels K. H. Scheel, Tanja B. Jensen, (unknown), Jannick Prentoe, Maria L. Knudsen, Anne Mette Hoegh, Jens Bukh	304
17	Highly Efficient JFH1‐Based Cell‐Culture System for Hepatitis C Virus Genotype 5a: Failure of Homologous Neutralizing‐Antibody Treatment to Control Infection 2008 ·The Journal of Infectious Diseases ·Tanja B. Jensen, Judith M. Gottwein, Troels K. H. Scheel, Anne Mette Hoegh, Jesper Eugen‐Olsen, Jens Bukh	96
18	Development of JFH1-based cell culture systems for hepatitis C virus genotype 4a and evidence for cross-genotype neutralization 2008 ·Proceedings of the National Academy of Sciences ·Troels K. H. Scheel, Judith M. Gottwein, Tanja B. Jensen, Jannick Prentoe, Anne Mette Hoegh, Harvey J. Alter, Jesper Eugen‐Olsen, Jens Bukh	159

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact